Wilke T J
Clin Chem. 1982 Oct;28(10):2051-6.
I evaluated Amerlex (Amersham International), Coat-A-Count (Diagnostic Products Corporation), Gammacoat (Clinical Assays), Immophase (Corning Medical), and Liquisol (Damon Diagnostics) radioimmunoassay kits for determinations of free thyroxin concentration in sera. Kit results for free thyroxin and the free thyroxin index and thyroxin/thyroglobulin ratio were compared for patients with thyroid disease and for subjects with normal and altered thyroglobulin binding capacity. Values for free thyroxin, free thyroxin index, and thyroxin/thyroglobulin clearly distinguished hyperthyroid and hypothyroid patients from euthyroid subjects. Each free thyroxin kit showed that fewer euthyroid patients with increased or decreased thyroglobulin binding capacity had values outside of normal limits than was indicated by kits for either free thyroxin index or thyroxin/thyroglobulin. The free thyroxin kits not only provided a better overall index of thyroid status in euthyroid patients who had alterations in thyroglobulin binding capacity than either of the indirect assessments of free thyroxin, but also supplied similar diagnostic information in thyroid disease.
我评估了Amerlex(阿美仙国际公司)、Coat - A - Count(诊断产品公司)、Gammacoat(临床检验公司)、Immophase(康宁医疗公司)和Liquisol(达蒙诊断公司)的放射免疫分析试剂盒用于测定血清中游离甲状腺素浓度。比较了甲状腺疾病患者以及甲状腺球蛋白结合能力正常和改变的受试者的游离甲状腺素、游离甲状腺素指数及甲状腺素/甲状腺球蛋白比值的试剂盒检测结果。游离甲状腺素、游离甲状腺素指数和甲状腺素/甲状腺球蛋白的值能明显区分甲状腺功能亢进和减退患者与甲状腺功能正常的受试者。每个游离甲状腺素试剂盒显示,与游离甲状腺素指数或甲状腺素/甲状腺球蛋白试剂盒相比,甲状腺球蛋白结合能力升高或降低的甲状腺功能正常患者中,游离甲状腺素值超出正常范围的人数更少。游离甲状腺素试剂盒不仅比游离甲状腺素的两种间接评估方法能更好地全面反映甲状腺球蛋白结合能力改变的甲状腺功能正常患者的甲状腺状态,而且在甲状腺疾病中提供了类似的诊断信息。